Combines Synopsis Solicitation- iPSC Differentiati

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q00878/PCA-NIMH-02470. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Oxford StemTech Ltd The Oxford Science Park Hayakawa Building Edmund Hally Road Oxford, UK to acquire scientific support services for the quality control of Induced Pluripotent Stem Cells (iPSCs) and use of a subset of these iPSC lines for generation and characterization of organoids.

• NAICS541714
• PSCQ301

• Sol_75N98026Q00878.pdf

  .pdf463 KBNot yet available

• JOHNSON, JOHN R
  johnsonjr@mail.nih.gov+1 000 000 0000